HNW
ABBV icon

High Note Wealth’s AbbVie ABBV Stock Holding History

High Note Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.72M Sell
7,916
-391
-5% -$86.7K 0.34% 52
2025
Q4 		$1.9M Sell
8,307
-169
-2% -$38.5K 0.37% 51
2025
Q3 		$1.96M Sell
8,476
-385
-4% -$78.4K 0.39% 53
2025
Q2 		$1.64M Sell
8,861
-11,362
-56% -$2.11M 0.38% 50
2025
Q1 		$4.24M Buy
20,223
+158
+0.8% +$30.7K 1.05% 27
2024
Q4 		$3.57M Buy
20,065
+132
+0.7% +$24.3K 0.93% 29
2024
Q3 		$3.94M Buy
19,933
+284
+1% +$53K 1.13% 24
2024
Q2 		$3.37M Buy
19,649
+227
+1% +$37.6K 1.03% 28
2024
Q1 		$3.54M Buy
19,422
+791
+4% +$136K 1.15% 27
2023
Q4 		$2.89M Buy
18,631
+33
+0.2% +$4.81K 1.09% 28
2023
Q3 		$2.77M Buy
18,598
+555
+3% +$81.5K 1.15% 26
2023
Q2 		$2.43M Sell
18,043
-998
-5% -$146K 0.99% 31
2023
Q1 		$3.03M Buy
19,041
+28
+0.1% +$4.28K 1.25% 25
2022
Q4 		$3.07M Sell
19,013
-23
-0.1% -$3.53K 1.29% 25
2022
Q3 		$2.92M Buy
19,036
+75
+0.4% +$10.8K 1.17% 25
2022
Q2 		$2.9M Buy
18,961
+445
+2% +$68K 1.13% 26
2022
Q1 		$3M Buy
18,516
+3,915
+27% +$569K 1.06% 29
2021
Q4 		$1.98M Buy
14,601
+801
+6% +$94.6K 0.67% 44
2021
Q3 		$1.49M Buy
13,800
+1,608
+13% +$184K 0.54% 51
2021
Q2 		$1.37M Buy
12,192
+560
+5% +$63.1K 0.5% 51
2021
Q1 		$1.26M Buy
11,632
+488
+4% +$52.2K 0.49% 50
2020
Q4 		$1.19M Buy
+11,144
New +$1.07M 0.51% 49

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

High Note Wealth's ABBV Position: Q1 2026 in Review

High Note Wealth reduced its AbbVie (ABBV) stake by 4.7% in Q1 2026, selling an estimated $86.7K and leaving 7,916 shares worth $1.72M. The position accounts for 0.34% of the portfolio, ranked #52.

High Note Wealth first reported a position in ABBV in Q4 2020 and has held it in 22 quarters since. The position peaked at $4.24M in Q1 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • High Note Wealth held 7,916 shares of AbbVie worth $1.72M as of Q1 2026.
  • High Note Wealth sold 391 AbbVie shares in Q1 2026, an estimated $86.7K.
  • AbbVie made up 0.34% of High Note Wealth's portfolio in Q1 2026, its #52 holding.
  • High Note Wealth first reported a position in AbbVie in Q4 2020 and has held it in 22 quarters since.
  • High Note Wealth's AbbVie position peaked at $4.24M in Q1 2025.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on High Note Wealth's 13F filing for Q1 2026, filed 11 May 2026.